Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3956177 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TDP1MAPK1CYP2A6KIF11 | |
| SCHEMBL17941356 | 1.00 | ALDH1A1 (0.53) | ALDH1A1TDP1MAPK1CYP2A6KIF11 | |
| SCHEMBL24871316 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPK1KIF11TSHR | |
| SCHEMBL16509905 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPK1KIF11TSHR | |
| SCHEMBL440244 | 0.88 | CYP2A6 (0.57) | ALDH1A1TDP1MAPK1CYP2A6TSHR | |
| SCHEMBL28912876 | 0.88 | CYP2A6 (0.57) | ALDH1A1TDP1MAPK1CYP2A6TSHR | |
| SCHEMBL17948170 | 0.87 | ALDH1A1 (0.71) | ALDH1A1TDP1MAPK1CYP2A6KIF11 | |
| SCHEMBL9846771 | 0.85 | KCNN4 (0.50) | ALDH1A1MAPK1KIF11TSHRKCNN4 | |
| SCHEMBL230628 | 0.82 | KCNN4 (0.53) | ALDH1A1MAPK1TSHRKCNN4ESR1 | |
| SCHEMBL7756315 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TDP1MAPK1KIF11TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-12-10 | — | — | US | disclosed |
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | BEIJING ETERNAL MATERIAL TECHNOLOGY CO., LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-10-20 | — | — | US | disclosed |
| CN-113764594-A | Heterocyclic compound and organic light-emitting device including the same | 三星显示有限公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-113636945-A | Compound and application thereof | 北京鼎材科技有限公司 | 2021-11-12 | — | — | CN | disclosed |
| EP-3480194-B1 | HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING SAME | LG CHEMICAL LTD (KR) | 2021-09-08 | — | — | EP | disclosed |
| EP-3480194-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2019-05-08 | — | — | EP | disclosed |
| US-20090227812-A1 | TETRAPHENYLMETHANE SKELETON-CONTAINING COMPOUND | FUJIFILM CORPORATION (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090227812-A1 | TETRAPHENYLMETHANE SKELETON-CONTAINING COMPOUND | FUJIFILM CORPORATION (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090227812-A1 | TETRAPHENYLMETHANE SKELETON-CONTAINING COMPOUND | FUJIFILM CORPORATION (JP) | 2009-09-10 | — | — | US | disclosed |
| CN-101115717-A | Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists | AVENTIS PHARMA INC (US) | 2008-01-30 | — | — | CN | disclosed |
| CN-101006092-A | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and therapeutic agents using the same | PFIZER (US) | 2007-07-25 | — | — | CN | disclosed |
| CN-1989115-A | * azole derivatives as histamine H3 receptor agents, their preparation and therapeutic use | LILLY CO ELI (US) | 2007-06-27 | — | — | CN | disclosed |
| CN-1867554-A | Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors | HOFFMANN LA ROCHE (CH) | 2006-11-22 | — | — | CN | disclosed |
| CN-1668303-A | Selective estrogen receptor modulators containing phenylsulfonyl groups | LILLY CO ELI (US) | 2005-09-14 | — | — | CN | disclosed |
| CN-1042539-C | 11,21-bisphenyl-19-norpregnane derivatives | AKZO NOBEL NV (NL) | 1999-03-17 | — | — | CN | disclosed |
| CN-1126727-A | 11,21-bisphenyl-19-norpregnane derivatives | AKZO NOBEL NV (NL) | 1996-07-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200219-A1 | A compound, an organic electroluminescent device and a display device | L1CAM, VDAC2, CD274 | ALDH1A1 125/4885TDP1 2385/4885MAPK1 1204/4885 |
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | CYP1A1, CYP1B1, CHRM1 | ALDH1A1 173/4885TDP1 2595/4885MAPK1 252/4885 |
| US-20090227812-A1 | TETRAPHENYLMETHANE SKELETON-CONTAINING COMPOUND | PAH, TSNAX, ZFX | ALDH1A1 4467/4885TDP1 2743/4885MAPK1 1101/4885 |
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | C1S, ARRB1, CRY1 | ALDH1A1 321/4885TDP1 3454/4885MAPK1 916/4885 |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | C1S, CNR1, ARRB1 | ALDH1A1 306/4885TDP1 3336/4885MAPK1 979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.